Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. MasterPharm LLC
EIR
•MasterPharm LLC•January 30, 2017

MasterPharm LLC – FDA EIR, Jan 30, 2017

Record Details

An FDA inspection of MasterPharm LLC, a compounding pharmacy in South Richmond Hill, NY, was conducted from January 17-30, 2017. This inspection served as a follow-up to a previous audit in 2015 that identified significant issues, including insanitary conditions and deficiencies in aseptic processing, which led to a Warning Letter. Operating under Section 503A of the Federal Food, Drug and Cosmetic Act, MasterPharm LLC prepares patient-specific sterile and non-sterile compounded drug products, ranging from injectables to topical preparations. During the current inspection, the FDA issued a Form 483 with two main observations. First, the firm failed to conduct adequate aseptic process simulations, a critical step for qualifying personnel in sterile compounding techniques. Second, the inspection revealed a failure to adequately depyrogenate stoppers used in the production of sterile drug products, posing a risk of bacterial endotoxin contamination. Additionally, the inspection noted discrepancies in stability data supporting the assigned "beyond use dates" for certain sterile preparations, specifically Trimix formulations, which had proposed expiry dates exceeding the available supporting data. The firm also lacked process validation for certain in-house sterilization methods. MasterPharm LLC is required to submit a written response to the Agency addressing these observations within fifteen business days.

Company
MasterPharm LLC
Inspection date
January 30, 2017
Product type
drugs
Office
New York District Office
People
  • Niesha Morris (other)
  • Lin Leung (company_representative)
  • Irving L. Wiesen
  • Stephen S. Laddy
  • Alice S. Tsao (Consumer Safety Officer at FDA)
View Company Profile

ID · 536cbf92-1776-45d1-ab7c-d12cbe68ca70

Violation Codes4
FD&C Act 503A21 CFR 820.198FD&C Act 503(b)21 CFR 820.100

Full citation text and observation details available on the Dashboard.

Other documents for MasterPharm LLC
  • 483 - 2020-06-15June 15, 2020
  • 483 - 2017-01-30January 30, 2017
  • STATE_REFERRAL_LETTER - 2017-01-17January 17, 2017
  • 483 - 2015-05-06May 6, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore MasterPharm LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.